Endo-illumination-aided SB combined with IVT hyaluronate for RRD
7 April 2021
| Sofia Rokerya
|
Retina / Uvea / Vitreous
|
Endo-illumination, Intravitreal injection of hyaluronate, Noncontact wide-angle viewing system, Rhegmatogenous retinal detachment, Scleral buckling
The authors report a retrospective non-randomised control trial that evaluated the efficacy and safety of 25-gauge illumination-aided scleral buckling (SB) combined with hyaluronate injection for the treatment of rhegmatogenous retinal detachment (RRD). Forty-five cases were included in this study. Twenty-five...
OCT choroidal signs for congenital retinal pigment epithelium hypertrophy
4 February 2021
| Annes Ahmeidat
|
Retina / Uvea / Vitreous
|
Choroid, Congenital hypertrophy of the pigment epithelium, Optical coherence tomography
Congenital hypertrophy of the retinal pigment epithelium (CHRPE) on ocular coherence tomography (OCT) has the characteristic sign of RPE thickening and hyper reflectivity. However, the underlying choroid characteristics remain under researched. This retrospective study utilised data from an ophthalmic oncology...
Microvasculature changes of mCNV after ranibizumab treatment using OCTA
4 February 2021
| Sofia Rokerya
|
Retina / Uvea / Vitreous
|
Myopic choroidal neovascularization, Optical coherence tomography angiography, Pathologic myopia
In this study the authors aim to evaluate the vascular changes of myopic choroidal neovascularisation (mCNV) after ranibizumab treatment using optical coherence tomography-angiography (OCTA). The 3×3 OCTA en face images were analysed for the absence / presence of mCNV, CNV...
Retinal vascular occlusion from gentamicin injection post-vitrectomy
4 February 2021
| Annes Ahmeidat
|
Retina / Uvea / Vitreous
|
Gentamicin, Macular ischemia, Retinal vascular occlusion, Vitrectomy
The authors present two case reports for the rare, but serious, complication of retinal vascular occlusion as a presumed result of subconjunctival injection following 25-gauge vitrectomy. Risk factors for the complication include: cardiovascular disease, retrobulbar anaesthesia, high intraocular pressure (IOP)...
Longitudinal changes in axial length in high myopia
This is a prospective, longitudinal, observational single centre study between May 2011 and September 2018, to determine the changes in the axial length (AL) longitudinally in patients with high myopia without other conformational abnormalities. Patients were divided into two groups:...
Is optic disc drusen a risk factor in young patients with anterior ischaemic optic neuropathy?
7 December 2020
| Tasmin Berman
|
Retina / Uvea / Vitreous
This retrospective cross-section multicentre study reviewed 65 patients all younger than 50-years-old with non-arteritic anterior optic neuropathy (NA-AION) between April 2017 and March 2019. The purpose of this study was to investigate if there was a link between Optic Disc...
OCT angiography sign after whiplash
7 December 2020
| Annes Ahmeidat
|
Retina / Uvea / Vitreous
Berlin’s oedema is a rare condition following blunt ocular injury and a rare finding after whiplash injury. This case describes a 48-year-old male who suffered a seventh vertebrae fracture from a traffic accident. Two days later, decreased left eye visual...
Clinical features of ocular syphilis
7 December 2020
| Su Young
|
Retina / Uvea / Vitreous
|
HIV, infectious uveitis, posterior uveitis, syphilis
The study looked at 24 patients (20 males, four females) with serological evidence of syphilitic infection who presented to a tertiary ophthalmic centre. Ocular involvement was the first manifestation of syphilitic disease in 96% and Human Immunodeficiency Virus (HIV) seropositivity...
Intravitreal Ziv-Aflibercept: safety analysis
7 December 2020
| Su Young
|
Retina / Uvea / Vitreous
|
Diabetic macular edema (DME), Intravitreal ziv, aflibercept (IVZ), Neovascular age related macular degeneration (n, AMD), Ziv, aflibercept, retinal venous occlusion (RVO)
Ziv-Aflibercept (Zaltrap; Sanofi-Aventis U.S LLS, Bridgewater, NJ) was originally introduced as an intravenous formulation for metastatic colorectal cancer. The adoption of Ziv-Aflibercept in ophthalmic practice was similar to bevacizumab, and reports have previously examined one to two year visual outcomes...
Visual acuity outcomes in Coat’s disease by classification stage
5 October 2020
| Jonathan Chan
|
Retina / Uvea / Vitreous
This is a retrospective study of 160 consecutive patients with Coat’s disease under the Shields classification, with Snellen visual acuity (VA) pre and post treatment. Affected eyes were categorised based on the Shields classification: Stage 1: retinal telangiectasia onlyStage 2a:...
Treat-and-extend regimen in treatment of patients with type 3 neovascularisation
5 October 2020
| Su Young
|
Retina / Uvea / Vitreous
Type 3 neovascularisation, also known as retinal angiomatous proliferation is a distinct subtype of neovascular AMD characterised by intraretinal neovascularisation. This retrospective study included 17 eyes diagnosed with type 3 neovascularisation who were changed from pro-re-nata (PRN) based treatment regime...
How accurate is the supplement content in both generic and branded ophthalmology supplements?
5 October 2020
| Tasmin Berman
|
Retina / Uvea / Vitreous
This prospective cross-section study compared the concentrations of Vitamin C, Vitamin E, Zinc, and Copper in five dietary supplements including both national and regional brands used for macular degeneration in the United States. They performed a comparative analysis using gas...
